Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoatrophy revisited.

M L Reitman1, E Arioglu, O Gavrilova

  • 1Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 8N-250, 10 Center Drive, Bethesda, MD 20892-1770, USA. mlr@helix.nih.gov

Trends in Endocrinology and Metabolism: TEM
|November 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential of CLSM in studying some modern and fossil palynological objects.

Journal of microscopy·2017
Same author

Acetylsalicylic acid protects erectile function in diabetic rats.

Andrologia·2014
Same author

Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice.

Diabetologia·2011
Same author

Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.

Diabetologia·2011
Same author

Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design.

Clinical pharmacology and therapeutics·2010
Same author

The changes in beta-adrenoceptor-mediated cardiac function in experimental hypothyroidism: the possible contribution of cardiac beta3-adrenoceptors.

Molecular and cellular biochemistry·2009
Same journal

Beyond fat storage: neuronal lipid droplets regulate whole-body metabolism.

Trends in endocrinology and metabolism: TEM·2026
Same journal

HDL resuscitates cells from ferroptosis.

Trends in endocrinology and metabolism: TEM·2026
Same journal

2-Methylbutyrylcarnitine (2MBC).

Trends in endocrinology and metabolism: TEM·2026
Same journal

Decoding growth hormone actions on human growth plate stem cells.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Androgen loss backfires: Brain gate for tumor immunity.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiology.

Trends in endocrinology and metabolism: TEM·2026
See all related articles

Lipoatrophy syndromes, a lack of body fat, cause insulin-resistant diabetes. Research shows this diabetes stems from fat loss, with leptin deficiency playing a role. Treatments like thiazolidinediones show promise.

Area of Science:

  • Endocrinology
  • Metabolic disorders
  • Genetics

Background:

  • Lipoatrophy syndromes are characterized by a significant paucity of adipose tissue.
  • Severe lipoatrophy is strongly associated with insulin-resistant diabetes mellitus (DM).
  • Etiologies for adipose tissue loss include genetic, immune, or infectious/drug-associated factors.

Purpose of the Study:

  • To investigate the mechanisms linking lipoatrophy to diabetes mellitus.
  • To explore the role of leptin deficiency in lipoatrophic diabetes.
  • To evaluate therapeutic strategies for metabolic control in lipoatrophy.

Main Methods:

  • Identification of causative mutations in Dunnigan-type familial partial lipodystrophy.
  • Experimental studies using lipoatrophic mouse models.

Related Experiment Videos

  • Clinical assessment of metabolic control with thiazolidinedione therapy.

    • Main Results:

    • Experiments confirmed that diabetes in lipoatrophic mice results from fat loss.
    • Leptin deficiency was identified as a contributing factor to the diabetes.
    • Thiazolidinedione therapy demonstrated efficacy in improving metabolic control.

    Conclusions:

    • The study elucidates the link between adipose tissue deficiency and insulin resistance.
    • Leptin plays a crucial role in the metabolic complications of lipoatrophy.
    • Pharmacological interventions can improve metabolic outcomes in patients with lipoatrophy.